Manufacturer record
Genip Formulation Pvt Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Genip Formulation Pvt Ltd (Himachal Pradesh) were declared Not of Standard Quality in September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: GFTB25844, Rabeprazole Gastro Resistant Tablets IP 20 mg (exp Aug 2027). SDTL, Andhra Pradesh, Vijayawada (state lab) found it not of standard quality: Assay & Dissolution Test of Rabeprazole. Listed in the September 2026 alert.
Records by type
2 records linked to Genip Formulation Pvt Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Rabeprazole Gastro Resistant Tablets IP 20 mg | Batch GFTB25844Mfg Sep 2025 · Exp Aug 2027 | Assay & Dissolution Test of RabeprazoleAssay | SDTL, Andhra Pradesh, VijayawadaState lab | Sep 2026 |
| Rabeprazole Gastro Resistant Tablets IP | Batch GFTB26191Mfg Apr 2026 · Exp Mar 2028 | Dissolution Test of RabeprazoleDissolution | SDTL, Andhra Pradesh, VijayawadaState lab | Sep 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.